Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Recreating lineage-specific cardiac cells from iPSCs

March 15, 2019

Acesion Pharma identifies new SK (Ca) 2.3 channel blockers

March 15, 2019

Apelin receptor agonists identified at Bristol-Myers Squibb

March 14, 2019

Pirfenidone partially reverses severe pulmonary arterial hypertension in rat models

March 8, 2019

Acesion Pharma divulges SK3 blockers

March 7, 2019

MyoKardia announces safety and efficacy data from PIONEER-OLE study of mavacamten

March 5, 2019

Healx partners with Boston Children's Hospital to advance drug discovery in Barth syndrome

March 4, 2019

C/EBPdelta identified as a therapeutic target for IVIG-resistant Kawasaki disease

Feb. 28, 2019

Improved lymphocyte access via development of a lymphatic-targeted dosing system

Feb. 28, 2019

Eidos initiates pivotal phase III study of AG-10 in ATTR-CM

Feb. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...